Co., Ltd. Class H ( ($HK:2235) ) has issued an update. MicroTech Medical (Hangzhou) Co., Ltd. announced that its LinX ...

The global blood glucose monitor market is set to expand from USD 16.5 billion in 2025 to USD 25.4 billion by 2030, growing ...

Following years in development, Finnish medtech GlucoModicum has unveiled its needle-free glucose monitoring patch, designed ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

FOR IMMEDIATE RELEASEGlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics ...

CEA-Leti has collaborated with STMicroelectronics to unveil a major step toward practical, continuous biochemical monitoring ...

CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).

Dexcom ’s board has confirmed that President and Chief Operating Officer Jacob S. Leach will assume the roles of President, Chief Executive Officer and director effective January 1, 2026, following ...

A method using light to measure blood glucose levels could save diabetes patients from frequent finger pricks every day.

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...